HomeNBTX • NASDAQ
Nanobiotix SA - ADR
$3.39
Feb 5, 5:20:00 PM GMT-5 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$3.46
Day range
$3.39 - $3.39
Year range
$2.76 - $7.65
Market cap
160.77M USD
Avg Volume
29.96K
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
4.64M182.08%
Operating expense
16.41M14.48%
Net income
-10.94M22.16%
Net profit margin
-235.4672.41%
Earnings per share
——
EBITDA
-11.62M5.65%
Effective tax rate
-0.66%—
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
66.34M206.69%
Total assets
86.68M114.52%
Total liabilities
108.46M15.15%
Total equity
-21.78M—
Shares outstanding
47.40M—
Price to book
-7.52—
Return on assets
-33.93%—
Return on capital
-107.38%—
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
-10.94M22.16%
Cash from operations
-2.92M66.22%
Cash from investing
-250.00K-52.91%
Cash from financing
-1.33M-24.18%
Net change in cash
-4.47M54.71%
Free cash flow
-7.44M9.68%
About
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
Founded
2003
Employees
110
Search
Clear search
Close search
Google apps
Main menu